Diagnostics Limited is a private Irish company operating in the $57
billion in-vitro diagnostics market. It’s Chairman and CEO is Brendan K
Farrell, a veteran of the diagnostics industry. The company is focussed
on applying molecular technology to the infectious disease segment of
the diagnostic market.